Page last updated: 2024-09-03

neurokinin a (4-10), beta-ala(8)- and atenolol

neurokinin a (4-10), beta-ala(8)- has been researched along with atenolol in 1 studies

Compound Research Comparison

Studies
(neurokinin a (4-10), beta-ala(8)-)
Trials
(neurokinin a (4-10), beta-ala(8)-)
Recent Studies (post-2010)
(neurokinin a (4-10), beta-ala(8)-)
Studies
(atenolol)
Trials
(atenolol)
Recent Studies (post-2010) (atenolol)
71025,4731,950852

Protein Interaction Comparison

ProteinTaxonomyneurokinin a (4-10), beta-ala(8)- (IC50)atenolol (IC50)
Beta-1 adrenergic receptorHomo sapiens (human)0.7468
Alpha-1D adrenergic receptorHomo sapiens (human)0.23
Alpha-1A adrenergic receptorHomo sapiens (human)0.23
Alpha-1B adrenergic receptorHomo sapiens (human)0.23

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Couture, R; Deschamps, K1

Other Studies

1 other study(ies) available for neurokinin a (4-10), beta-ala(8)- and atenolol

ArticleYear
The ventral tegmental area as a putative target for tachykinins in cardiovascular regulation.
    British journal of pharmacology, 2005, Volume: 145, Issue:6

    Topics: Acetates; Adrenergic beta-Antagonists; Animals; Atenolol; Behavior, Animal; Benzamides; Benzazepines; Blood Pressure; Dopamine D2 Receptor Antagonists; Glutamic Acid; Heart Rate; Indoles; Male; Neurokinin A; Neurokinin-1 Receptor Antagonists; Peptide Fragments; Piperidines; Quinolines; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Neurokinin-1; Receptors, Neurokinin-2; Receptors, Neurokinin-3; Substance P; Ventral Tegmental Area

2005